TRX818 for cell activation

Catalog number
B1223-5
Name
TRX818 for cell activation
Size
5 mg
Price
208.00 EUR
Supplier

Details

Description
TRX818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities. TRX-818, upon oral administration appears to induce cancer cell apoptosis and inhibits cancer cell proliferation. TRX818 also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures.
Peptide sequence
N/A
CAS number
1256037-58-7
Molecular weight
393.21
Category
Biochemicals
Other name
Sodium (2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin-5-yl)phosphonate
Molecular formula
C₁₆H₁₁FNNaO₅P
Physical appearance
Crystalline solid
Supplied with
N/A
Is this a salt?
No
Is it cell-permeable?
Yes
Purification
≥98% by HPLC
Reconstitute instructions
DMSO
Storage condition
-20°C
Shipping condition
gel pack
Maximum time for storage
36 months
Storage instructions
Protect from air and light
Tissue
cell
Additional description
For cells, cell lines and tissues in culture till half confluency.